Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit - Additional Information (Details)

v3.24.1.1.u2
Shareholders' Deficit - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 04, 2024
Mar. 31, 2024
Dec. 31, 2023
Equity [Line Items]      
Common stock, shares authorized   600,000,000 600,000,000
Common stock, par value   $ 0.0001 $ 0.0001
Voting rights   Each share of common stock entitles the shareholder to one vote.  
Common stock, shares issued   201,279,662 199,413,917
Payments of stock issuance costs   $ 44  
Preferred stock, shares authorized   50,000,000 50,000,000
Preferred stock, par value   $ 0.0001 $ 0.0001
Preferred stock, shares issued   0 0
Preferred stock, shares outstanding   0 0
Rights Agreement      
Equity [Line Items]      
Acquire percentage 15.00%    
Maximum      
Equity [Line Items]      
Common stock, shares authorized   600,000,000  
Preferred stock, shares authorized   50,000,000  
Series A Junior Participating Preferred Stock | Rights Agreement      
Equity [Line Items]      
Preferred stock, par value $ 0.0001    
Warrants exercise price per share $ 5.35